Waters Corporation Acquires Halo Labs

May 21, 2025

Waters Corporation has acquired Halo Labs, a venture-backed developer of the Aura imaging platform for subvisible and visible particle analysis used in cell, gene and protein therapy development and QA/QC. The deal brings Halo Labs' high-throughput, low-volume particle analysis technology into Waters' Wyatt Technology portfolio to expand Waters' analytical and bioprocessing testing capabilities for large-molecule therapies.

Targets
Halo Labs
Industry
Medical Devices
Location
California, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.